EN  |  DE
Home   |  Kontakt   |  Standorte
Drug Coated Balloon
 
Home > Services > Events & News > Rückblick 2010

Rückblick 2010

April 2010

08.-10 April 2010
76. Jahrestagung der DGC
Mannheim, Deutschland
http://www.dgk.org

Freitag, 9. April 2010 (Saal 19)
Hotline: Studien / Register
(V950) PEPCAD III Studie – randomisierter Vergleich eines DES mit einer Kombination aus DCB und BMS
B. Scheller (Homburg/Saar)

Samstag, 10. April 2010 (Saal 18)
Arbeitsgruppe „Interventionelle Kardiologie“ VIDEO CASE-Sitzung
Interventionelle Innovationen – was ist wirklich ein Fortschritt? (V1243) Video Case Bifurkations-Behandlung: BMS, DES oder DCB?
B. Scheller (Homburg/Saar)

Poster
Clin Res Cardiol 99, Suppl 1, April 2010
P1002 – Paclitaxel-beschichtete SeQuent® Please Ballonkatheter: – „Real Life Scenario“ bei therapierefraktären in-Stent Restenosen
B. Cremers1, Y. P. Clever1, W. von Scheidt2, M. Böhm1, B. Scheller1

Clin Res Cardiol 99, Suppl 1, April 2010
P997 – Patients’risk characteristics as predictors for clinically driven TLR and MACE within an ‘all comer’ DES Registry 
M. Leschke1, V. T. Nhan2, V. Palacios3, I. G. Horvath4, C. C. Ling5, V. A. Ivanov6, D. Tresukosol7, P. Avraamides8, M. Waliszewski9, A. Schneider1

Deutsche Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V.

Pressetext DGK 04/2010
Beschichteter Ballon für Koronargefäße und periphere Gefäße
Statement von Prof. Dr. Bruno Scheller, Homburg/Saar
Prof. Dr. Bruno Scheller
Klinische und Experimentelle Interventionelle Kardiologie, Universität des Saarlandes, Campus Homburg
mehr als PDF-Download

Pressetext DGK 04/2010
Neue Ballonkatheter mit Medikamentenbeschichtung verhindern Wiederverengung von Herz- und Beingefäßen
Prof. Dr. Eckart Fleck, Pressesprecher
Deutsche Gesellschaft für Kardiologie (DGK)
mehr als PDF-Download

Pressetext DGK 04/2010
PEPCAD-III-Studie: DCB und BMS alternativ zu DES
Statement von Prof. Dr. Bruno Scheller, Homburg/Saar
Prof. Dr. Bruno Scheller
Klinische und Experimentelle Interventionelle Kardiologie, Universität des Saarlandes, Campus Homburg
mehr als PDF-Download

Cardio News

2. Letter zum 76. Jahrestagung der Deutschen Gesellschaft für Kardiologie 2010
Hektischer Aktionismus ist fehl am Platz
Vorhang auf für Deutschlands größtes Kardiologen-Portal
Stent geht wieder zu DE-Ballon hilft
mehr als PDF-Download

EURO PCR Paris, May 25-28, 2010

B. Braun and Medrad PCR Satellite Symposium “What Preclinical and Clinical Results have Taught us about the PACCOCATH® Drug Eluting Balloon (DEB) Coating Technology: Not all Drug Eluting Balloons are Created Equal”

Chairman: Eric Eeckhout/Ulrich Speck

www.europcr.com

Introduction: Development of the DEB Concept
Ulrich Speck (Charité Berlin, Germany)

Biological Concepts and Lessons Learned from the PACCOCATH® Technology in Pre-Clinical Animal Models
Juan Granada (Orangeburg, USA)

Animal Data and Clinical Results of Different Drug Eluting Balloon Systems
Bruno Scheller (Homburg/Saar, Germany)

The PEPCAD Clinical Trial Program
Detlef Mathey (Hamburg, Germany)

Practical Application of the PACCOCATH® Technology – Tricks and Tips
Franz-Xaver Kleber (Potsdam, Germany)

Paccocath® for Treatment of Peripheral Artery Disease
Gunnar Tepe (Tuebingen, Germany)

Future Horizons for the PACCOCATH® Technology
Nicolas Diehm (Bern, Switzerland)

Conclusion and Q&A Session with Panellists
Eric Eeckhout (Lausanne, Switzerland)

The complete panel discussion is available as a webcast containing the original presentations and statements on cardio-sympoisum.org

September 2010

September 21-25, 2010
TCT 2010 – Transcatheter Cardiovascular Therapeutics
B. Braun Vascular Systems, booth number 2035
Washington Convenion Center, Washington D.C., USA
www.tctconference.com

In addition, different lectures about Sequent® Please with PACCOCATH® Technology will be held:

The Drug Eluting Stent Summit (Part 2): Next Generation DES, Bioabsorbable Stents and Drug-Coated Balloons

German Consensus Group Recommendations for DCB Development
Date: Wednesday, September 22, 2010
Time: 2:22 p.m. to 2:37 p.m.
Presenter: Bruno Scheller

The PACCOCATH® (Cotavance And Sequent Please) Paclitaxel DCB Technology and Compressive Review of All Completed and Planned Clinical Trials
Date: Wednesday, September 22, 2010
Time: 2:37 p.m. to 2:52 p.m.
Presenter: Detlef G. Mathey

First Report Investigations I – PERFECT STENT TRIAL
A Prospective, Randomized Trial Evaluating a Paclitaxel-Eluting Balloon in Patients Treated with Endothelial Progenitor Cell Capturing Stents for De Novo Coronary Artery Disease

Date: Thursday, September 23, 2010
Time: 12:30 to 12:40 p.m.
Place: Washington Convention Center, Main Arena, Ballrooms ABC, Level 3
Presenter: Jochen Wöhrle
Moderated Discussion: Juan F. Granada

Featured Clinical Research III – PEPCAD-CTO
A prospective Nonradomized Study of Paclitaxel-Eluting Balloons After Bare Metal Stent Placement in Successfully Recanalized Chronic Total Occlusions.
Date: Friday, September 24, 2010
Time: 7:15 p.m. to 7:25 p.m.
Place: Washington Convention Center, Room 143B
Presenter:  Gerald S. Werner
  
Furthermore B. Braun and Medrad organized a breakfast symposium on September 23, 2010.
Time:  Breakfast at 6:30 a.m./ Program: 7:00 a.m.-8:00 a.m.
Place:  Washington Convention Center, Room 144A

The title is : “What Pre-Clinical and Clinical Results Have Taught Us About the PACCOCATH® Drug-Coated Balloon Technology: Not all Drug-Coated Balloons are Created Equal”

Introduction (Moderator: Robert Schwartz)
Standardization of Technology and Testing for Drug Coated Balloons

Clinical Evidence of the PACCOCATH® Technology – Overview of Coronary Clinical Studies
Speaker: Detlef G. Mathey

Practical Application of the PACCOCATH® Technology – Tips & Tricks
Speaker: Bruno Scheller

PACCOCATH® Technology Development Update – Insights into Safety and Efficacy of Latest Generation Cotavance Drug Coated Balloon
Speaker: Juan Granada

PACCOCATH® Technology in Peripheral Applications – Prior Experience and Future Directions
Speaker: William Gray

Discussion among the panel and audience!